Institutional Manager · CIK 0001643354
Lion Point Capital, LP
NEW YORK, NY · File #028-17316
Latest AUM
$19.3M
Positions
39
Top-10 Concentration
48.5%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | MINERALYS THERAPEUTICS INC | MLYS | -28,500 | -$1.0M | -$63,570 |
| EXITED | AVADEL PHARMACEUTICALS PLC | G29687103 | -59,700 | -$911,619 | $0 |
| EXITED | KINIKSA PHARMACEUTICALS INTL | G52694109 | -23,400 | -$908,622 | $0 |
| EXITED | INSMED INC | 457669307 | -6,250 | -$900,063 | $0 |
| REDUCE | ARCUTIS BIOTHERAPEUTICS INC | ARQT | -30,050 | -$872,652 | +$359,707 |
| REDUCE | MERSANA THERAPEUTICS INC | 59045L205 | -25,660 | -$742,344 | +$545,339 |
| NEW | CUE BIOPHARMA INC | CUE | +2,202,854 | +$672,752 | $0 |
| REDUCE | BRIDGEBIO PHARMA INC | BBIO | -8,300 | -$634,867 | +$326,515 |
| NEW | SAREPTA THERAPEUTICS INC | SRPT | +28,500 | +$613,320 | $0 |
| REDUCE | REGENXBIO INC | RGNX | -31,150 | -$448,560 | +$274,312 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202539 pos · $19.3M
- 13F HOLDINGS REPORTQ/E Sep 202527 pos · $17.6M
- 13F HOLDINGS REPORTQ/E Jun 202519 pos · $14.7M
- 13F HOLDINGS REPORTQ/E Mar 202521 pos · $15.7M
- 13F HOLDINGS REPORTQ/E Dec 202419 pos · $19.1M
- 13F HOLDINGS REPORTQ/E Sep 202425 pos · $44.9M
- 13F HOLDINGS REPORTQ/E Jun 202427 pos · $54.9M
- 13F HOLDINGS REPORTQ/E Mar 202432 pos · $179.0M
- 13F HOLDINGS REPORTQ/E Dec 202331 pos · $224.4M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | MILESTONE PHARMACEUTICALS IN | MIST | 755,000 | $1.5M | 7.89% |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 4,450 | $1.3M | 6.79% |
| 3 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 67,500 | $889,650 | 4.60% |
| 4 | FENNEC PHARMACEUTICALS INC | FENC | 112,434 | $865,742 | 4.48% |
| 5 | JASPER THERAPEUTICS INC | JSPRW | 465,000 | $850,950 | 4.40% |
| 6 | BENITEC BIOPHARMA INC | BNTC | 62,000 | $835,140 | 4.32% |
| 7 | ROYALTY PHARMA PLC | RPRX | 21,400 | $826,896 | 4.28% |
| 8 | GERON CORP | GERN | 578,000 | $762,960 | 3.95% |
| 9 | SYNDAX PHARMACEUTICALS INC | SNDX | 36,000 | $756,360 | 3.91% |
| 10 | ARDELYX INC | ARDX | 128,650 | $750,030 | 3.88% |
| 11 | CUE BIOPHARMA INC | CUE | 2,202,854 | $672,752 | 3.48% |
| 12 | DISC MEDICINE INC | IRON | 8,100 | $643,221 | 3.33% |
| 13 | SAREPTA THERAPEUTICS INC | SRPT | 28,500 | $613,320 | 3.17% |
| 14 | BIOHAVEN LTD | BHVN | 51,700 | $583,693 | 3.02% |
| 15 | HUMACYTE INC | HUMAW | 500,000 | $480,250 | 2.49% |
| 16 | KURA ONCOLOGY INC | KURA | 46,000 | $477,940 | 2.47% |
| 17 | SERES THERAPEUTICS INC | MCRB | 31,570 | $469,762 | 2.43% |
| 18 | COMPASS PATHWAYS PLC | CMPS | 58,000 | $400,200 | 2.07% |
| 19 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 42,000 | $391,440 | 2.03% |
| 20 | REGENXBIO INC | RGNX | 26,600 | $383,040 | 1.98% |